Pages that link to "Q34973856"

The following pages link to Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome (Q34973856):

Displaying 48 items.

• What can we learn about autism from studying fragile X syndrome? (Q24613049) (← links)
• Emerging Pharmacotherapies for Neurodevelopmental Disorders (Q24619170) (← links)
• Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses (Q24634270) (← links)
• Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders (Q26748761) (← links)
• Behavioral phenotypes of genetic mouse models of autism (Q26781456) (← links)
• Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. (Q26866506) (← links)
• Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit (Q27339352) (← links)
• Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. (Q28261563) (← links)
• FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype. (Q30365865) (← links)
• Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice. (Q30376422) (← links)
• Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype (Q30389603) (← links)
• Stem cells and modeling of autism spectrum disorders (Q30401824) (← links)
• Modeling fragile X syndrome in the Fmr1 knockout mouse (Q30420595) (← links)
• Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges (Q30465038) (← links)
• Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders (Q30469044) (← links)
• Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk (Q30485438) (← links)
• Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome (Q30500501) (← links)
• Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome (Q30505749) (← links)
• GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. (Q33543082) (← links)
• Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. (Q33607288) (← links)
• Lithium: a promising treatment for fragile X syndrome (Q33777951) (← links)
• Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome (Q33827442) (← links)
• Optogenetic insights on the relationship between anxiety-related behaviors and social deficits (Q33906973) (← links)
• Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome (Q34142731) (← links)
• Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule (Q34431654) (← links)
• A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis (Q35148962) (← links)
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders (Q35197096) (← links)
• Neuroprotective action of lithium in disorders of the central nervous system (Q35212429) (← links)
• Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice (Q35243625) (← links)
• Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome (Q35492486) (← links)
• R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome (Q36077206) (← links)
• Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. (Q36245800) (← links)
• Sociability and brain development in BALB/cJ and C57BL/6J mice (Q36327061) (← links)
• The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice. (Q36379639) (← links)
• Development of home cage social behaviors in BALB/cJ vs. C57BL/6J mice (Q36560206) (← links)
• Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle. (Q36990260) (← links)
• Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome (Q37213114) (← links)
• Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases. (Q38738836) (← links)
• Programming social behavior by the maternal fragile X protein. (Q40667152) (← links)
• Behavioral responses to physical vs. social novelty in male and female laboratory rats (Q41103816) (← links)
• Deficient Sleep in Mouse Models of Fragile X Syndrome (Q41619835) (← links)
• Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. (Q42512974) (← links)
• Deletion of Fmr1 results in sex-specific changes in behavior (Q42655986) (← links)
• Brief report: altered social behavior in isolation-reared Fmr1 knockout mice (Q44473103) (← links)
• Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats (Q47105240) (← links)
• A candidate circuit approach to investigating autism (Q47575039) (← links)
• Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model. (Q55155951) (← links)
• The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome (Q64245388) (← links)